Akcea Therapeutics Competitors and Similar CompaniesClear all
Akcea Therapeutics's competitors and similar companies include Biogen.
 Akcea Therapeutics Akcea Therapeutics is a late-stage biopharmaceutical company developing drugs for the treatment of cardiometabolic diseases caused by lipid disorders. |  Biogen Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases. | |
Founding Date | Founding Date 2014 | Founding Date 1978 |
Type | Type Subsidiary | Type Public |
Tags | ||
Locations | Locations Boston, US HQ Cambridge, US | Locations Cambridge, US HQ Vicente López, AR Macquarie Park, AU Wien, AT Machelen, BE São Paul, BR Toronto, CA see more |
Employees | Employees 100 | Employees 7,605 |
Financial | ||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $9.9b (FY, 2025) |
Operating ⚠ | ||
Phase I Trials Products | Phase I Trials Products 2 (Jun, 2017) | Phase I Trials Products 4 (FY, 2024) |
Phase I/II Trials Products | Phase I/II Trials Products 1 (Jun, 2017) | Phase I/II Trials Products 1 (FY, 2022) |
Phase II Trials Products | Phase II Trials Products 1 (Jun, 2017) | Phase II Trials Products 6 (FY, 2024) |
Phase III Trials Products | Phase III Trials Products 1 (Jun, 2017) | Phase III Trials Products 11 (FY, 2024) |
For sources of this data, please see the company profile
View Company Profiles
Biogen
HQ
Cambridge, US
Employees
7,605
Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases.
View company